Sanofi, Regeneron unveil positive Praluent cholesterol study

PARIS (Reuters) - French drugmaker Sanofi and U.S. partner Regeneron said a late-stage study of their Praluent injection showed it reduced the need for patients with an inherited form of high cholesterol to have bad cholesterol removed from their blood.

http://ift.tt/xePdMM

from Reuters: Health News
via animenewspro